comprehensive -WSS

comprehensive

author：fashion 2025-09-27 21:27:10 - browse：88

-- health policy coverage from STAT — Protestors outside America's Health Insurance Plans headquarters. Courtesy People's Action

WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest health insurance lobbying group to protest against restrictions to coverage in private Medicare plans.

The protesters were crammed into an already busy part of the city. A 10-minute walk from the Capitol building and a block off the National Mall, the headquarters for America’s Health Insurance Plans is located in a part of Washington that is crowded with tourists during the summer. The protesters, organized by a group called People’s Action, left messages on the sidewalk in chalk that included “You make us sick,” and “for-profit health ‘care’ killed my mom.”

People’s Action has worked with high-profile progressive lawmakers, including Sen. Elizabeth Warren (D-Mass.), to push for lower drug prices and Medicare for All.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： In same hospitals, Black patients receive fewer opioids than white patients

hotspot

WSS

Brain MRIs reveal impact of 'toxic stress' on Black children

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Novel spinal cord stimulator treats paralysis without surgery

Empower primary care with adequate payments and technology

Deliver public health messages at the right time

AI for drug discovery: Experts on separating hype from reality

hotspot

comprehensive

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

How a small hospital in rural Puerto Rico survived Hurricane Maria

How to save PrEP access — and even expand it

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

In age of alternative facts, a scholarly course on calling out crap

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Psychedelics group wrestles with new pharma identity

As health system earnings go up, health insurance stocks go down

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

entertainment

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Friends ask where James Watson's attitudes about race came from

Black vets could get higher VA benefits if race not used in lung test

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

hotspot

focus

focus

explore